A relatively large number of food processors received notices from the U.S. Food and Drug Administration (FDA) in the agency’s latest round of warning letters. Four seafood processors were notified about inadequacies in their Hazard Analysis and Critical Control Points (HACCP) plans. A StarKist facility in Ecuador had “significant deviations” from their HACCP plans for canned and pouched tuna, according to FDA, while Van Oriental Food of Dallas, TX, allegedly did not have complete HACCP plans for its egg roll-production process. Hawaii-based Pacific Hi-Tak had problems with their HACCP plan for vacuum-packed yellowtail, and Yandi New York Trading Co. of Brooklyn, NY, was warned for lacking a HACCP plan for its imported dried anchovies, FDA letters stated. Four cattle producers were cited for illegal levels of drug residues in cattle they sold for slaughter. These included Kentucky-based producer Michael Hatcher, who allegedly sold a dairy cow for slaughter with excessive levels of sulfamethazine in its liver tissue, while DG Farms in California sold a cow for slaughter with too much desfuroylceftiofur in its kidney tissue, FDA stated. Murmac Farms LLC of Pennsylvania sold a veal calf containing neomycin, a drug for which there is no established allowable presence in veal calves, according to FDA. Wisconsin-based Emerald Dairy sold a dairy cow with excessive levels of penicillin and flunixin in tissue samples, the FDA letter read. Maria Distribution Sari of Senegal was cited for a number of problems related to the Emergency Permit Control regulation and the Acidified Foods regulation, FDA alleged. In Vietnam, West Food Company also had deviations from the Emergency Permit Control regulation, the Thermally Processed Low-Acid Foods Packaged in Hermetically Sealed Containers regulation, and the Acidified Foods regulation, according to the agency. Finally, Buffalo Gills LLC, a Baltimore acidified-foods processor, similarly had problems with the Emergency Permit Control regulation and Acidified Foods regulation, FDA stated, and some of their products were found to be misbranded for failing to declare known allergens. In each letter, FDA requested that the companies provide written responses detailing steps taken to bring the facilities into compliance with food safety laws and regulations, to correct violations cited in the letters, and to prevent their recurrence. Recipients of these warning letters have 15 working days from receipt to outline specific steps they have taken to come into compliance with the law.